LIU Ruicheng,KONG Ling,SUN Ye,et al.Research progress about effective components of Astragali Radix in the intervention of diabetic retinopathy and its mechanism[J].ZHONGGUO YAOFANG,2023,34(11):1404-1408.
LIU Ruicheng,KONG Ling,SUN Ye,et al.Research progress about effective components of Astragali Radix in the intervention of diabetic retinopathy and its mechanism[J].ZHONGGUO YAOFANG,2023,34(11):1404-1408. DOI: 10.6039/j.issn.1001-0408.2023.11.23.
Research progress about effective components of Astragali Radix in the intervention of diabetic retinopathy and its mechanism
Diabetic retinopathy (DR) is a common complication of diabetes, which causes a great threat to the health of human vision. Recent studies have shown that saponins, polysaccharides and flavonoids in Astragali Radix regulate phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin pathway, silent information regulator 1/nuclear factor erythroid 2-related factor 2 pathway, B-cell lymphoma-2 and other signaling pathways by acting on nuclear factor-κB, hypoxia-inducible factor-1α, glial fibrillary acidic protein, glutamine synthetase, aldose reductase, multiple miRNA and other related targets, so as to exert anti-inflammatory, anti-microangiopathy, anti-neurodegenerative disease and anti-apoptosis, and then achieve the purpose of treating DR.
关键词
糖尿病视网膜病变黄芪有效成分作用机制
Keywords
Astragali Radixactive componentmechanisms
references
ABU EL-ASRAR A M,AL-MEZAINE H S. Advances in the treatment of diabetic retinopathy[J]. Saudi J Ophthalmol,2011,25(2):113-122.
PANG B,LI Q W,QIN Y L,et al. Traditional Chinese medicine for diabetic retinopathy:a systematic review and meta-analysis[J]. Medicine (Baltimore),2020,99(7):e19102.
NY V,HOUŠKA M L,PAVELA R,et al. Potential bene- fits of incorporating Astragalus membranaceus into the diet of people undergoing disease treatment:an overview[J]. J Funct Foods,2021,77:104339.
HU C,JIA W P. Therapeutic medications against diabetes:what we have and what we expect[J]. Adv Drug Deliv Rev,2019,139:3-15.
LEE D,LEE D H,CHOI S,et al. Identification and isolation of active compounds from Astragalus membranaceus that improve insulin secretion by regulating pancreatic β-cell metabolism[J]. Biomolecules,2019,9(10):618.
LIU X,WANG B,SUN Y,et al. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity[J]. Cell Cycle,2019,18(22):3147-3159.
JIN Q,HAO X F,XIE L K,et al. A network pharmaco- logy to explore the mechanism of Astragalus membranaceus in the treatment of diabetic retinopathy[J]. Evid Based Complement Alternat Med,2020,2020:8878569.
SU H F,SHAKER S,KUANG Y,et al. Phytochemistry and cardiovascular protective effects of Huang-Qi (Astragali Radix)[J]. Med Res Rev,2021,41(4):1999-2038.
CHANG X,CHEN X,GUO Y,et al. Advances in chemical composition,extraction techniques,analytical me- thods,and biological activity of Astragali Radix[J]. Mo- lecules,2022,27(3):1058.
WANG C J,HE F,HUANG Y F,et al. Discovery of chemical markers for identifying species,growth mode and production area of Astragali Radix by using ultra-high-performance liquid chromatography coupled to triple quadrupole mass spectrometry[J]. Phytomedicine,2020,67:153155.
ZHANG J Q,WU C X,GAO L,et al. Astragaloside Ⅳ derived from Astragalus membranaceus:a research review on the pharmacological effects[J]. Adv Pharmacol,2020,87:89-112.
TANG Z,HUANG G. Extraction,structure,and activity of polysaccharide from Astragali Radix[J]. Biomed Pharmacother,2022,150:113015.
LIU P,PENG Q H,TONG P,et al. Astragalus polysaccharides suppresses high glucose-induced metabolic memory in retinal pigment epithelial cells through inhibiting mitochondrial dysfunction-induced apoptosis by regulating miR-195[J]. Mol Med,2019,25(1):21.
SHENG Z,JIANG Y,LIU J,et al. UHPLC-MS/MS analysis on flavonoids composition in Astragalus membranaceus and their antioxidant activity[J]. Antioxidants (Basel),2021,10(11):1852.
ZHANG Y,CHEN C,ZHANG J. Effects and significance of formononetin on expression levels of HIF-1α and VEGF in mouse cervical cancer tissue[J]. Oncol Lett,2019,18(3):2248-2253.
RÜBSAM A,PARIKH S,FORT P E. Role of inflammation in diabetic retinopathy[J]. Int J Mol Sci,2018,19(4):942.
FORRESTER J V,KUFFOVA L,DELIBEGOVIC M. The role of inflammation in diabetic retinopathy[J]. Front Immunol,2020,11:583687.
FERNANDEZ-ROBREDO P,GONZÁLEZ-ZAMORA J,RECALDE S,et al. Vitamin D protects against oxidative stress and inflammation in human retinal cells[J]. Antioxidants (Basel),2020,9(9):E838.
HERNÁNDEZ C,ARROBA A I,BOGDANOV P,et al. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes[J]. J Clin Med,2020,9(8):2579.
WANG Y,REN T J,ZHENG L C,et al. Astragalus saponins inhibits lipopolysaccharide-induced inflammation in mouse macrophages[J]. Am J Chin Med,2016,44(3):579-593.
UEMURA A,FRUTTIGER M,D’AMORE P A,et al. VEGFR1 signaling in retinal angiogenesis and microinflammation[J]. Prog Retin Eye Res,2021,84:100954.
ARRIGO A,ARAGONA E,BANDELLO F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy[J]. Ann Med,2022,54(1):1089-1111.
LAZZARA F,TROTTA M C,PLATANIA C B M,et al. Stabilization of HIF-1α in human retinal endothelial cells modulates expression of miRNAs and proangiogenic growth factors[J]. Front Pharmacol,2020,11:1063.
MARCHESI N,FAHMIDEH F,BOSCHI F,et al. Ocular neurodegenerative diseases:interconnection between retina and cortical areas[J]. Cells,2021,10(9):2394.
ROSSINO M G,DAL MONTE M,CASINI G. Relationships between neurodegeneration and vascular damage in diabetic retinopathy[J]. Front Neurosci,2019,13:1172.
LIU Y,LI L L,PAN N X,et al. TNF-α released from retinal Müller cells aggravates retinal pigment epithelium cell apoptosis by upregulating mitophagy during diabetic retinopathy[J]. Biochem Biophys Res Commun,2021,561:143-150.
QIU A W,HUANG D R,LI B,et al. IL-17A injury to retinal ganglion cells is mediated by retinal Müller cells in diabetic retinopathy[J]. Cell Death Dis,2021,12(11):1057.
SUBIRADA P V,PAZ M C,RIDANO M E,et al. A journey into the retina:Müller glia commanding survival and death[J]. Eur J Neurosci,2018,47(12):1429-1443.
THAKUR S,GUPTA S K,ALI V,et al. Aldose reductase:a cause and a potential target for the treatment of diabetic complications[J]. Arch Pharm Res,2021,44(7):655-667.
DING Y Z,YUAN S T,LIU X Y,et al. Protective effects of astragaloside Ⅳ on db/db mice with diabetic retinopathy[J]. PLoS One,2014,9(11):e112207.
YANG S,ZHANG J,CHEN L. The cells involved in the pathological process of diabetic retinopathy[J]. Biomed Pharmacother,2020,132:110818.
PAVAN B,DALPIAZ A. Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies[J]. Drug Discov Today,2018,23(9):1672-1679.
VASISHTA S,UMAKANTH S,ADIGA P,et al. Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes[J]. Vascul Pharmacol,2022,142:106933.
TANG X,LI X,ZHANG D,et al. Astragaloside-Ⅳ alle- viates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2[J]. Bioengineered,2022,13(4):8240-8254.
WANG T,ZHANG Z W,SONG C P,et al. Astragaloside-Ⅳ protects retinal pigment epithelial cells from apoptosis by upregulating miR‑128 expression in diabetic rats[J]. Int J Mol Med,2020,46(1):340-350.
PENG Q H,TONG P,GU L M,et al. Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204/SIRT1 axis in retinal pigment epithelial cells[J]. Biosci Rep,2020,40(1):BSR20192121.
GAO L M,FU S,LIU F,et al. Astragalus polysaccharide regulates miR-182/bcl-2 axis to relieve metabolic memory through suppressing mitochondrial damage-mediated apoptosis in retinal pigment epithelial cells[J]. Pharmaco- logy,2021,106(9/10):520-533.